HONDAPOWER2022-10-012022-12-31 HONDAPOWER2022-10-012022-12-31 HONDAPOWER2022-10-012022-12-31in-bse-fin:OneOperatingExpenses01Member HONDAPOWER2022-10-012022-12-31in-bse-fin:FourOperatingExpenses01Member HONDAPOWER2022-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 522064 HONDAPOWER NOTLISTED Honda India Power Products Limited Equity 2022-04-01 2023-03-31 2023-02-06 2023-01-23 INR Lakhs Third quarter 16:40:00 17:09:00 2023-02-06 2023-02-06 Not applicable Single segment Power Products 2022-10-01 2022-12-31 Unaudited Standalone 3388500000.00 28900000.00 3417400000.00 1587000000.00 265500000.00 165500000.00 326500000.00 600000.00 49100000.00 594100000.00 2988300000.00 429100000.00 0.00 429100000.00 117300000.00 -7700000.00 109600000.00 0.00 319500000.00 0.00 0.00 0.00 0.00 319500000.00 -100000.00 319400000.00 0.00 0.00 101400000.00 10 31.50 31.50 0.00 0.00 31.50 31.50 1. The above financial results of the Company have been prepared in accordance with the recognition and management principles of Indian Accounting Standards ( Ind AS ) as notified under the Companies (Indian Accounting Standards) Rules, 2015 and relevant amendment rules issued thereafter. 2. The above results were reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on February 6, 2023. 3. The Company is in the business of “Power Products” which is a single segment in accordance with Ind AS-108 Operating Segment notified pursuant to Companies (Accounting Standards) Rule, 2015. 4. The Company’s major export is to its fellow subsidiaries located in the United States of America (USA), Canada, Australia, United Kingdom (UK), countries in European Union (EU) and European Free Trade Association (EFTA). In line with the regulatory requirements of the above-mentioned countries, the Company is required to do product line testing (PLT) on regular intervals for one of the key products being sold to these countries to comply with emission norms. Results of such testing done during the financial year 2021-22, were not in confirmation with required norms in case of Australia, UK, countries in EU/EFTA and in case of USA and Canada, testing results exceeded the declarations on the products but same were within the required norms in respective countries. As a precautionary measure, the Company stopped dispatches during March 2022. The Company is still assessing the coverage and its monetary impact which may be in the form of replacement cost of components in the products and regulatory fees, if any. Considering the above-mentioned facts, it is not practicable for the management to make reliable estimate regarding the obligation of the Company in respect of the above matter. Accordingly, there exists contingent liability in respect of this matter and no provision has been recognized in the current unaudited financial results for the quarter and nine months ended 31 December 2022. During this year, the Company has restored export sales to USA and Canada under the revised declaration and to UK, EU and EFTA within prescribed norms. Single segment 2022-04-01 2022-12-31 Unaudited Standalone 9329900000.00 141900000.00 9471800000.00 5093300000.00 782000000.00 -403400000.00 1022400000.00 1700000.00 147300000.00 1765200000.00 8408500000.00 1063300000.00 0.00 1063300000.00 299700000.00 -29200000.00 270500000.00 0.00 792800000.00 0.00 0.00 0.00 0.00 792800000.00 -200000.00 792600000.00 0.00 0.00 101400000.00 10 78.16 78.16 0.00 0.00 78.16 78.16 Other Expenses 594100000.00 Other Expenses 1765200000.00 -100000.00 -300000.00 0.00 -100000.00